Recognizing the Potential for Overdiagnosis: Are High-Sensitivity Cardiac Troponin Assays an Example?

Affiliations

¹ The University of Sydney, Sydney, New South Wales, Australia (K.J.B., L.S.).
² Bond University, Gold Coast, Queensland, Australia (J.D., P.G.).
³ University of Queensland, Brisbane, Queensland, Australia (L.C.).
⁴ The University of Sydney, Ingham Institute of Applied Medical Research, and South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia (I.A.H.).
⁵ Cabrini Institute and Monash University, Melbourne, Victoria, Australia (R.B.).
⁶ Wiser Healthcare, The University of Sydney, Sydney, New South Wales, Australia (A.B.).

Katy J L Bell et al. Ann Intern Med. 2019.

. 2019 Feb 19;170(4):259-261.

doi: 10.7326/M18-2645. Epub 2019 Feb 5.

¹ The University of Sydney, Sydney, New South Wales, Australia (K.J.B., L.S.).
² Bond University, Gold Coast, Queensland, Australia (J.D., P.G.).
³ University of Queensland, Brisbane, Queensland, Australia (L.C.).
⁴ The University of Sydney, Ingham Institute of Applied Medical Research, and South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia (I.A.H.).
⁵ Cabrini Institute and Monash University, Melbourne, Victoria, Australia (R.B.).
⁶ Wiser Healthcare, The University of Sydney, Sydney, New South Wales, Australia (A.B.).

No abstract available

MeSH terms